A framework published in npj Aging proposes that the mitochondrial state of cardiac macrophages determines whether the ageing heart resolves or perpetuates low-grade inflammation in heart failure with preserved ejection fraction. When immune cell energy demand chronically outstrips recovery capacity, macrophages shift toward glycolytic, pro-inflammatory programming that sustains fibrosis and diastolic stiffness. Framing HFpEF as a workload–recovery imbalance places immunometabolism, rather than contractile failure, at the centre of a condition that accounts for roughly half of heart failure cases in older adults.
Key Points
- Cardiac macrophage mitochondrial state governs inflammation resolution in ageing hearts
- HFpEF reframed as chronic imbalance between immune workload and recovery
- Glycolytic macrophage programming sustains fibrosis and diastolic stiffness
Longevity Analysis
Diastolic dysfunction has long been treated as a mechanical problem, but the determinant here is metabolic capacity within the cells that patrol and repair cardiac tissue. The same principle that governs muscle adaptation — demand must be matched by recovery — applies to immune cells embedded in the myocardium, which links inflammatory load, mitochondrial function and the heart's ability to remain compliant with age. Reducing persistent inflammatory stimuli and protecting mitochondrial reserve becomes a cardiovascular strategy, not merely an immune one, and it explains why recovery-oriented interventions such as sleep quality, metabolic control and training periodization carry cardiac consequences that standard ejection fraction measurements never capture.
Original published by Nature - npj Aging, by Li-Yu Lin.